Clinical trial
Omega Interferon Alone or in Combination With Ribavirin in Subjects With…
NCT00097045 · Intarcia Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00097045 |
|---|---|
| Title | Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C |
| Official title | Phase 2 Study of Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C |
| Lead sponsor | Intarcia Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | omega interferon, Ribavirin |
| Enrollment | 90 |
| Start date | Nov 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Nov 18, 2004 |
| Last update posted | Aug 23, 2007 |
| Countries | Russia |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: